Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
script written starting at a higher dosing level of 6 mg+
Third-party lab tested for purity
Retatrutide Dosage Based on Clinical Studies: The Scientific Foundation Dosing guidelines for retatrutide are based on the Phase 2 data published by Jastreboff and colleagues in NEJM (2023) and, as of 2026, on the first Phase 3 data from TRIUMPH-4
Semaglutide has also now been approved by the FDA and the UKs Medicines and Healthcare products Regulatory Agency to reduce cardiovascular risk
US$ 25.94
US$ 20.48
US$ 20.91
US$ 28.08
US$ 22.94
